FDA to investigate metals found in tampons after study; study's co-author 'excited' over decision
The FDA will now investigate metals found in tampons following the results of a recent study. The study's co-author weighs in ...
GlobalData on MSN5d
FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor
The clinical hold was placed on three studies investigating azenosertib in June after two patients died due to presumed ...
FDA advisers say phenylephrine doesn't work — so why do DayQuil, Theraflu and other popular decongestants still include it?
With cold and flu season approaching, here's the latest on where things stand with phenylephrine, which the FDA has deemed ...
Milk Recall Sparks Warning Across the Country
Under FDA regulations, manufacturers must label if a product contains or may contain any of the nine major food allergens, ...
UPI11d
FDA to investigate toxic metals found in tampons
The U.S. Food and Drug Administration announced Tuesday that it will launch an independent review into any possible effects ...
News Nation on MSN1d
Lactaid Milk recalled in 27 states for almond exposure
( NewsNation) — Lactaid, a lactose-free dairy milk, has been recalled in 27 states after possible exposure to almonds, posing a risk to those with tree nut allergies.
Another AZ county joins federal program to combat drug trafficking
Yavapai County will be part of the High Intensity Drug Trafficking Area program, which opens up federal resources to police ...
FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment
Monday, the FDA removed partial clinical holds on Rezolute, Inc.’s (NASDAQ:RZLT) RZ358 (ersodetug), a potential treatment for ...
WebMD11d
FDA Investigates Tampons for Potential Lead and Metal Risks
Manufacturers must test the product and its component materials before, during, and after manufacturing,” the FDA wrote in the announcement of its own upcoming study. “Before a product is ...
FierceBiotech4d
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided ...